Search Results - "Nomura, Hiroyuki"
-
1
Editorial Comment to Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan, 2014 update
Published in International journal of urology (01-06-2017)Get full text
Journal Article -
2
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
Published in Journal of human genetics (01-04-2018)“…The hereditary breast and ovarian cancer (HBOC) registration system of Japan was established by the Japanese HBOC Consortium. The first trial was registered in…”
Get full text
Journal Article -
3
A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan
Published in Scientific reports (01-02-2024)“…Approximately 500,000 women are diagnosed with cervical cancer annually, with high-grade cervical intraepithelial neoplasia (CIN) estimated to be 20 times…”
Get full text
Journal Article -
4
Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial
Published in Cancer science (01-09-2019)“…Nivolumab is a human monoclonal antibody against the immune checkpoint receptor programmed death‐1, inhibiting binding to programmed death‐ligand 1 or 2 (PD‐L1…”
Get full text
Journal Article -
5
A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells
Published in Molecules (Basel, Switzerland) (01-10-2021)“…The role of sialic acids on MUC1 in peritoneal dissemination of ovarian cancer cells was investigated. A human ovarian carcinoma cell line, ES-2, was…”
Get full text
Journal Article -
6
Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia
Published in Scientific reports (25-01-2021)“…Persistent HPV infection associated with immune modulation may result in high-grade squamous intraepithelial lesions (CIN)2/3. Currently, there is little…”
Get full text
Journal Article -
7
Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan
Published in International journal of clinical oncology (01-02-2022)“…Background As the population ages in developed countries, the number of Pap smears for cervical cancer screening of older women is increasing. There is concern…”
Get full text
Journal Article -
8
Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan
Published in Journal of human genetics (01-05-2022)“…We previously reported that L63X and Q934X are BRCA1 common founder variants in Japan. So far, there have been no reports of a correlation between such BRCA…”
Get full text
Journal Article -
9
Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age
Published in Scientific reports (28-09-2022)“…Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their…”
Get full text
Journal Article -
10
Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome
Published in Japanese journal of clinical oncology (16-12-2020)“…Abstract Background To establish an individualized surgical strategy for lymphadenectomy in ovarian cancer patients with the germline BRCA1 and BRCA2…”
Get full text
Journal Article -
11
A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer
Published in International journal of clinical oncology (01-10-2021)“…Background Advanced relapsed ovarian cancer has a poor prognosis, and treatment options are limited. Methods This phase I trial investigated the dosage,…”
Get full text
Journal Article -
12
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
Published in Journal of gynecologic oncology (01-07-2022)“…and mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a…”
Get full text
Journal Article -
13
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients
Published in International journal of clinical oncology (01-02-2022)“…Background This study aimed to investigate the clinical benefit of dose-dense paclitaxel plus carboplatin (TC) with bevacizumab therapy for advanced ovarian,…”
Get full text
Journal Article -
14
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Published in Journal of gynecologic oncology (01-03-2018)“…Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical…”
Get full text
Journal Article -
15
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary
Published in International journal of gynecological cancer (01-11-2014)“…Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer with a distinct clinical behavior. There are marked geographic…”
Get more information
Journal Article -
16
Parametric standing wave generation of a shallow reflection plane in a nonrigid sample for use in a noninvasive blood glucose monitor
Published in Journal of biomedical optics (01-03-2019)“…When monitoring a moist sample using mid-infrared spectroscopy, its thickness must be <100 μm to avoid light absorption from the water. Therefore, we propose…”
Get full text
Journal Article -
17
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Published in Oncotarget (22-09-2017)“…Drug repositioning is an alternative strategy redirecting existing drugs for new disease. We have previously reported an antitumor effect of statins,…”
Get full text
Journal Article -
18
Evaluating the importance of routine drainage following laparoscopic pelvic lymph node dissection for gynecological malignancies
Published in International journal of gynecology and obstetrics (01-06-2021)“…Objective To determine the efficacy of drainage following pelvic lymph node (PLN) dissection, especially for cases involving laparoscopic surgery. Methods In…”
Get full text
Journal Article -
19
Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
Published in BioMed research international (01-01-2014)“…Ovarian cancer has a poor prognosis because early detection is difficult and recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of…”
Get full text
Journal Article -
20
Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer
Published in Japanese journal of clinical oncology (01-11-2017)“…Interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) is currently one of the preferred treatment options for advanced ovarian, fallopian tube…”
Get full text
Journal Article